Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 19/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3131899 | 0.95 | IDH1 (0.53) | IDH1 | |
| SCHEMBL10934346 | 0.81 | IDH1 (0.54) | IDH1 | |
| SCHEMBL10726805 | 0.81 | IDH1 (0.54) | IDH1 | |
| SCHEMBL7087631 | 0.81 | IDH1 (0.54) | IDH1 | |
| SCHEMBL11856342 | 0.81 | IDH1 (0.54) | IDH1 | |
| SCHEMBL7087767 | 0.81 | IDH1 (0.54) | IDH1 | |
| SCHEMBL11858015 | 0.77 | IDH1 (0.70) | IDH1 | |
| SCHEMBL7087597 | 0.76 | IDH1 (0.61) | IDH1 | |
| SCHEMBL14649294 | 0.76 | IDH1 (0.36) | IDH1 | |
| SCHEMBL7094059 | 0.75 | IDH1 (0.59) | IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024127414-A1 | A COSMETIC COMPOSITION FOR ACNE CONTROL AND METHODS THEREOF | L'OREAL (FR) | 2024-06-20 | — | — | WO | claimed |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-07-13 | — | — | US | claimed |
| CN-115916147-A | Anti-acne composition | 欧莱雅 | 2023-04-04 | — | — | CN | claimed |
| EP-4153127-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-03-29 | — | — | EP | claimed |
| WO-2021234014-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2021-11-25 | — | — | WO | claimed |
| US-20080119527-A1 | Composition for combating the localized hyperpigmentation of dark skin | L'OREAL (FR) | 2008-05-22 | — | — | US | claimed |
| EP-1900353-A1 | Composition to combat localised hyperpigmentation in dark skin types | L'OREAL (FR) | 2008-03-19 | — | — | EP | claimed |
| EP-4739279-A1 | RED ALGAE BIOMASS EXTRACT, AND COSMETIC USE THEREOF FOR ELIMINATING SKIN IMPERFECTIONS | Fermentalg (FR) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025012135-A1 | RED ALGAE BIOMASS EXTRACT, AND COSMETIC USE THEREOF FOR ELIMINATING SKIN IMPERFECTIONS | FERMENTALG (FR) | 2025-01-16 | — | — | WO | disclosed |
| US-20240253381-A1 | PROCESS FOR COLOURING A BASE COSMETIC COMPOSITION | L'OREAL (FR) | 2024-08-01 | — | — | US | disclosed |
| WO-2024127414-A1 | A COSMETIC COMPOSITION FOR ACNE CONTROL AND METHODS THEREOF | L'OREAL (FR) | 2024-06-20 | — | — | WO | disclosed |
| EP-3091958-B1 | COSMETIC COMPOSITION COMPRISING CATIONIC SURFACTANT(S), ANTIDANDRUFF AGENT(S), LIQUID NON-SILICEOUS FATTY SUBSTANCE(S), AND NON-POLYMERIC THICKENING AGENT(S) | OREAL (FR) | 2024-04-03 | — | — | EP | disclosed |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | L'OREAL (FR) | 2023-07-13 | — | — | US | disclosed |
| US-20070105734-A1 | Composition for washing keratin materials and cosmetic treatment process using said composition | L'OREAL S.A. (FR) | 2007-05-10 | — | — | US | disclosed |
| EP-1779843-A1 | Washing composition for keratinous materials and process for cosmetic treatment therefore | L'Oréal (FR) | 2007-05-02 | — | — | EP | disclosed |
| US-6579907-B1 | Gelling agent is crosslinked acrylic polymer | L'OREAL S.A. (FR) | 2003-06-17 | — | — | US | disclosed |
| US-6469033-B1 | TOPICAL TREATMENT OF SKIN INFECTIONS WHICH ARE CAUSED BY FUNGI AND BACTERIA | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-10-22 | — | — | US | disclosed |
| EP-0928193-B1 | USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SKIN DISEASES | AVENTIS PHARMA GMBH (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-1064916-A1 | Cosmetic compositions containing an amphoteric polymer and an anti-dandruff agent and their uses | L'OREAL (FR) | 2001-01-03 | — | — | EP | disclosed |
| US-6162834-A | Foaming oil-in-water emulsion based on nonionic surfactants, a fatty phase and a crosslinked cationic or anionic polymer, and its use in topical applications | L'OREAL (FR) | 2000-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105734-A1 | Composition for washing keratin materials and cosmetic treatment process using said composition | KRT18, DSG1, DSC1 | IDH1 3099/4885 |
| US-20230218641-A1 | ANTI-ACNE COMPOSITIONS | CUTA, EBP, ACMSD | IDH1 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.